Zacks Rating on Quidel Corporation (QDEL)

Quidel Corporation (QDEL) : 2 brokerage houses believe that Quidel Corporation (QDEL) is a Strong Buy at current levels. 1 Analyst considers the fundamentals to be worthy of a Buy recommendation. 4 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Quidel Corporation (QDEL). Zacks Investment Research suggests a Strong Buy with a rank of 1.The median of all the 7 Wall Street Analysts endorse the stock as a Buy with a rating of 2.29.

Quidel Corporation (QDEL) : 5 Wall Street analysts covering Quidel Corporation (QDEL) believe that the average level the stock could reach for the short term is $21.2. The maximum price target given is $26 and the minimum target for short term is around $16, hence the standard deviation is calculated at $4.15.


Quidel Corp. has dropped 1.91% in the last five trading days, however, the shares have posted positive gains of 9.67% in the last 4 weeks. Quidel Corp. is up 31.48% in the last 3-month period. Year-to-Date the stock performance stands at 1.65%. Quidel Corporation (NASDAQ:QDEL): stock turned positive on Tuesday. Though the stock opened at $21.46, the bulls momentum made the stock top out at $22.04 level for the day. The stock recorded a low of $21.37 and closed the trading day at $21.55, in the green by 1.13%. The total traded volume for the day was 84,609. The stock had closed at $21.31 in the previous days trading.

Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions primarily include applications in infectious diseases, womens health and gastrointestinal diseases. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics and wellness screening centers. It markets its products in the United States through a network of national and regional distributors, and a direct sales force. Internationally, it sells and markets primarily through distributor arrangements. Its diagnostic solutions are used in the detection and diagnosis of many critical diseases and other medical conditions, including infectious diseases, womens health, autoimmune diseases, bone health, thyroid diseases and fecal occult blood.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.